Q9P-77282-09951 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-23
Registered in v-safe
2021-01-23
Dose 1 — Moderna
2021-01-23
Health check-in — day 0, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-01-24
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain, Swelling · Fatigue or tiredness

Adult check-in
2021-01-26
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Headache, Fatigue or tiredness

Adult check-in
2021-02-15
Health check-in — day 21, dose 1
Feeling: Good

Adult check-in
2021-02-20
Dose 2 — Moderna
2021-02-26
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-16
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-08-21
Survey response — 6 months, dose 2
MedDRA: Dyspnoea, Heart rate increased, Palpitations — Feeling: Poor · Be unable to do your normal daily activities

Free text: Heart palpitations and repeated elevated heart rate. Shortness of breath.

MedDRA releases: 2021-09,2024-11 · check-in free text available
2022-02-23
Survey response — 12 months, dose 2
MedDRA: Heavy menstrual bleeding, Immunodeficiency, Menstruation irregular — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Heavy heavy bleeding and irregular cycle and immunodeficiency

MedDRA releases: 2024-11 · check-in free text available
2022-02-23
Report sent to call center — 12 months, dose 2
Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-02-24
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-23	Moderna
2	2021-02-20	Moderna

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 9 — 6 months, dose 2

2021-08-21

Symptoms: Heart palpitations and repeated elevated heart rate. Shortness of breath.

Release 11 — 12 months, dose 2

2022-02-23

Symptoms: Heavy heavy bleeding and irregular cycle and immunodeficiency

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Dyspnoea	✓	·	✓
SD	Heart rate increased	✓	·	✓
SD	Heavy menstrual bleeding	·	·	✓
SD	Immunodeficiency	·	·	✓
SD	Menstruation irregular	·	·	✓
SD	Palpitations	✓	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release